Using hyaluronic acid to protect, heal, and repair tissue and skin is Anika’s specialty. It also employs the acid in products to combat osteoarthritis.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Information
| Location | Bedford, MA |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Fortune 500 Rank | - |
| Fortune 500 Profile | - |
| Current Streak | 1 |
| Years on List | 1 |
| CEO | Charles H. Sherwood |
| Website | http://www.anikatherapeutics.com |
Revenue, Net Income
| Revenue Past Four Quarters | 87 |
| Net Income Past Four Quarters | 27 |
Growth Rates
| EPS 3 yr Annual Growth Rate | 57% |
| Rev 3 yr Annual Growth Rate | 16% |
| Total Return 3 yr Annual Rate | 34% |
| Beat S&P 3 yr Total Return? | yes |
Rank
| EPS Growth Rank | 41 |
| Revenue Growth Rank | 99 |
| Total Return Rank | 67 |
